19 related articles for article (PubMed ID: 38444047)
1. Exploring the Potential Biological Activities of Pyrazole-Based Schiff Bases as Anti-Diabetic, Anti-Alzheimer's, Anti-Inflammatory, and Cytotoxic Agents:
Naglah AM; Almehizia AA; Al-Wasidi AS; Alharbi AS; Alqarni MH; Hassan AS; Aboulthana WM
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794225
[TBL] [Abstract][Full Text] [Related]
2. Coumarin-furo[2,3-
Wang T; Gao Y; Wu F; Luo L; Ma J; Hu Y
RSC Med Chem; 2024 May; 15(5):1565-1577. PubMed ID: 38784474
[TBL] [Abstract][Full Text] [Related]
3. Ensemble-Based Virtual Screening Led to the Discovery of Novel Lead Molecules as Potential NMBAs.
Zhang Y; Ge G; Xu X; Wu J
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731447
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis,
Aziz NAAM; George RF; El-Adl K; Mahmoud WR
RSC Adv; 2022 Apr; 12(20):12913-12931. PubMed ID: 35496328
[TBL] [Abstract][Full Text] [Related]
5. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR
Al-Wahaibi LH; Mohammed AF; Abdel Rahman FES; Abdelrahman MH; Gu X; Trembleau L; Youssif BGM
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2218602. PubMed ID: 37254958
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of Non-Covalent Imidazo[1,2-
Kumar M; Joshi G; Arora S; Singh T; Biswas S; Sharma N; Bhat ZR; Tikoo K; Singh S; Kumar R
Molecules; 2021 Mar; 26(5):. PubMed ID: 33803355
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents.
Yang X; Hou Z; Wang D; Mou Y; Guo C
Bioorg Med Chem Lett; 2020 Dec; 30(23):127557. PubMed ID: 32949719
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline-isoxazole-piperazine conjugates as EGFR-targeting agents.
Ali MI; Thirukovela NS; Kumar GB; Dasari G; Badithapuram V; Manchal R; Bandari S
Chem Biol Drug Des; 2024 Mar; 103(3):e14499. PubMed ID: 38444047
[TBL] [Abstract][Full Text] [Related]
10. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
